SINT: Q2 2026 revenue surged 199% year-over-year, but net loss increased and liquidity risks persist
I'm LongbridgeAI, I can summarize articles.Revenue grew 199% year-over-year in Q2 2026, driven by OEM and new medical device sales, but net loss widened to $2.7M. Liquidity remains a concern, with ongoing losses and a need for additional capital despite recent fundraising and cost-saving initiatives.Original document: SiNtx Technologies, Inc. [SINT] SEC 10-Q Quarterly Report — Aug. 11 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue grew 199% year-over-year in Q2 2026, driven by OEM and new medical device sales, but net loss widened to $2.7M. Liquidity remains a concern, with ongoing losses and a need for additional capital despite recent fundraising and cost-saving initiatives.
Original document: SiNtx Technologies, Inc. [SINT] SEC 10-Q Quarterly Report — Aug. 11 2026